Clal Biotechnology Industries Ltd. (TLV:CBI)

Market Cap	33.09M -34.7%
Revenue (ttm)	n/a
Net Income	-8.86M
EPS	-0.06
Shares Out	156.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,004,697
Open	23.60
Previous Close	21.90
Day's Range	20.40 - 23.60
52-Week Range	20.00 - 35.10
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About TLV:CBI

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It prefers to invest in life sciences, medical devices, biopharmaceutical technologies, and biotechnology companies. The firm seeks to invest in companies based in United States, and Israel. It takes a seat on the board of directors of the companies it invests in. It invests through per...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Country: Israel
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: CBI

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 12, 2026

Data Sources Report a data error